Skip to Main Content

Author Details

Richard J Rebello
University of Melbourne
2015
18
14
PMIDPaper TitleJournal TitlePublished Year
34830967A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease.Cancers (Basel)2021
33542230Prostate cancer.Nat Rev Dis Primers2021
32357309CRISP3 expression drives prostate cancer invasion and progression.Endocr Relat Cancer2020
32147317Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features.Clin Oncol (R Coll Radiol)2020
30610102<i>TP53</i> and Prognosis in mCRPC Survival: Biology or Coincidence?Clin Cancer Res2019
31534053mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans.JCI Insight2019
31556460Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expression.EMBO J2019
30808988The influence of BRCA2 mutation on localized prostate cancer.Nat Rev Urol2019
31061140Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.Mol Cell Proteomics2019
30728288Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.Sci Transl Med2019
29111105PIM activity in tumours: A key node of therapy resistance.Adv Biol Regul2018
30049486Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.Eur Urol2018
29581176Identification of <i>Pik3ca</i> Mutation as a Genetic Driver of Prostate Cancer That Cooperates with <i>Pten</i> Loss to Accelerate Progression and Castration-Resistant Growth.Cancer Discov2018
29695504AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.J Biol Chem2018
28212321Therapeutic Approaches Targeting MYC-Driven Prostate Cancer.Genes (Basel)2017
26780304From Sphingosine Kinase to Dihydroceramide Desaturase: A Structure-Activity Relationship (SAR) Study of the Enzyme Inhibitory and Anticancer Activity of 4-((4-(4-Chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II).J Med Chem2016
27486174The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.Clin Cancer Res2016
25436982Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity.Oncotarget2015
  • 1 - 18 of 18

Recommended Authors

Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 2
Alexandra Corella
Fred Hutchinson Cancer Research Center
Career Start Year 2015
Number of shared co-authors 1
Natalie Kurganovs
Australian Prostate Cancer Research Centre Epworth
Career Start Year 2015
Number of shared co-authors 4
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 1
Himisha Beltran
Dana-Farber Cancer Institute
Career Start Year 2010
Number of shared co-authors 8
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 1
Susana Miranda
The Institute of Cancer Research
Career Start Year 2008
Number of shared co-authors 0
Leigh Ellis
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 2007
Number of shared co-authors 3
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 0
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 0
Adam Foye
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 3
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 6
Wassim Abida
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 8
Amina Zoubeidi
University of British Columbia
Career Start Year 2000
Number of shared co-authors 10
Eleni Efstathiou
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 7
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Career Start Year 2000
Number of shared co-authors 7
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Johann S de Bono
The Institute for Cancer Research
Career Start Year 1999
Number of shared co-authors 9
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 3
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Career Start Year 1997
Number of shared co-authors 7
Felix Y Feng
UCSF Medical Center-Mount Zion
Career Start Year 1997
Number of shared co-authors 8
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 3
Edwin M Posadas
Cedars-Sinai Medical Center
Career Start Year 1993
Number of shared co-authors 4
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 10
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 10
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 3
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 7

Collaborators

Gail P Risbridger
Biomedicine Discovery Institute, Monash University
Co-authored papers 8
Renea A Taylor
Peter MacCallum Cancer Centre
Co-authored papers 5
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Co-authored papers 4
Robert G Bristow
University of Toronto
Co-authored papers 4
Richard B Pearson
Co-authored papers 3
Luke A Selth
Adelaide Medical School, University of Adelaide
Co-authored papers 3
Mark Frydenberg
Monash University
Co-authored papers 2
Melissa Papargiris
Biomedicine Discovery Institute, Monash University
Co-authored papers 2
Matthew J Watt
Co-authored papers 2
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 2
Ivan Topisirovic
McGill University
Co-authored papers 2
Daniel K Nomura
University of California berkeley
Co-authored papers 1
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Co-authored papers 1
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
John J McNeil
Co-authored papers 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Clemens D Cohen
Medical Clinic and Policlinic IV, University of Munich
Co-authored papers 1
Arun A Azad
Peter MacCallum Cancer Centre
Co-authored papers 1
Andrew T Chan
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 1
Matthew J Smalley
European Cancer Stem Cell Research Institute, Cardiff University
Co-authored papers 1
Damien Bolton
University of Melbourne
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 1
Maja T Lindenmeyer
University Medical Center Hamburg-Eppendorf
Co-authored papers 1
David C Johnson
University of North Carolina School of Medicine
Co-authored papers 1
David Clouston
Co-authored papers 1
Heather Thorne
Peter MacCallum Cancer Centre
Co-authored papers 1
Peter G Kerr
Co-authored papers 1
Release 1.2